Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,221Revenue (TTM) $M4,010Net Margin (%)-83.5Altman Z-Score-1.0
Enterprise Value $M9,976EPS (TTM) $-15.0Operating Margin %-86.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-97.9Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %--Quick Ratio0.8Cash flow > EarningsY
Price/Sales0.55-y EBITDA Growth Rate %--Current Ratio1.0Lower Leverage y-yY
Price/Free Cash Flow6.1y-y EBITDA Growth Rate %--ROA % (ttm)-19.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-62.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)-24.0Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ENDP is held by these investors:



ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Campanelli PaulPresident, CEO 2017-03-16Buy2,300$10.72-6.81view
Hutson Nancy JDirector 2017-03-09Sell5,325$10.82-7.67view
KIMMEL ROGER HDirector 2016-11-15Sell14,000$17.38-42.52view
HIGGINS ARTHUR JDirector 2016-05-11Buy5,000$13.8-27.61view
KIMMEL ROGER HDirector 2016-05-10Buy7,000$15.53-35.67view
HIGGINS ARTHUR JDirector 2016-05-10Buy11,000$15.42-35.21view
Campanelli PaulGroup President, Generics 2016-05-10Buy13,000$15.53-35.67view
INGRAM DOUGLAS SDirector 2016-05-05Sell4,513$26.59-62.43view
Spengler WilliamDirector 2016-03-17Buy1,000$29.2-65.79view
Spengler WilliamDirector 2016-03-16Buy1,000$35.24-71.65view

Quarterly/Annual Reports about ENDP:

News about ENDP:

Articles On GuruFocus.com
Aytu BioScience May Lead the Way in Low T Feb 28 2017 
Weitz Funds Comments on Endo International Jan 26 2017 
4 Stocks Reach Their 3-Year Lows Jan 21 2017 
Wally Weitz Comments on Endo Nov 08 2016 
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
US Market Indexes Reach New Highs Aug 09 2016 
Weitz Funds Comments on Endo International Jul 20 2016 
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary Jul 20 2016 

More From Other Websites
BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Mar 20 2017
Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA Mar 16 2017
Frontier Communications, Rubicon Project Plunge into Wednesday’s 52-Week Low Club Mar 15 2017
FDA panel: Endo opioid painkiller's risks outweigh its benefits Mar 15 2017
How Endo's FDA Committee Vote Affects Egalet Mar 15 2017
[$$] FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks Mar 14 2017
Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER Mar 14 2017
Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER Mar 14 2017
FDA deals blow to Endo over Opana ER Pain Med Mar 14 2017
Risks of Endo's opioid painkiller outweigh benefits: FDA panel Mar 14 2017
[$$] FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks Mar 14 2017
FDA: Risk of Endo's opioid painkiller outweigh benefits Mar 14 2017
Risk of Endo's opioid painkiller outweigh benefits: FDA Panel Mar 14 2017
New Strong Sell Stocks for March 9th Mar 09 2017
Why Endo International (ENDP) Could Be Positioned for a Slump Mar 08 2017
Trump’s Tweets Trigger a Sell-Off in the Healthcare Sector Mar 08 2017
ENDO INTERNATIONAL PLC Financials Mar 07 2017
ETFs with exposure to Endo International Plc : March 6, 2017 Mar 06 2017
Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange Mar 03 2017
Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange Mar 03 2017
Endo reports 4Q loss Feb 28 2017
Canada's TMX seeks part of Saudi Aramco listing Feb 08 2017
Endo Announces Appointments and Updates to Executive Management Team Dec 21 2016
Endo Announces Appointment of Blaise Coleman as Chief Financial Officer Dec 20 2016
Endo Reports Third Quarter 2016 Financial Results Nov 08 2016
Endo Strengthens Leadership Team with Appointment of Two Key Executives Nov 07 2016
Endo Begins Shipment of Generic SEROQUEL XR® Nov 01 2016
Endo Announces Departure of Chief Financial Officer Oct 20 2016
Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016 Oct 18 2016
Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX®... Sep 30 2016
Endo Names Paul Campanelli President and Chief Executive Officer Sep 23 2016
Endo's President and CEO Adopts 10b5-1 Trading Plan Aug 18 2016
Endo Announces OPANA® ER Regulatory Update Aug 12 2016
US STOCKS-Nasdaq hits record high, other indexes hover near highs Aug 09 2016
US STOCKS-Wall Street catches its breath after recent rally Aug 09 2016
Endo Reports Second Quarter 2016 Financial Results Aug 08 2016
Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals Aug 08 2016
Endo Announces Issuance of Vasostrict® Patent Jun 28 2016
Exclusive: Speciality drugmaker Endo explores asset sales - sources Jun 27 2016
Exclusive: Specialty drugmaker Endo explores asset sales - sources Jun 27 2016
Endo Announces FDA Advisory Committee Meeting For OPANA® ER Jun 15 2016
Endo Announces Local Qualitest Scholarship Program Award Recipients Jun 10 2016
Robbins Arroyo LLP: Endo International plc (ENDP) Misled Shareholders According to a Recently Filed... Jun 02 2016
US STOCKS-Wall St ends up after jobs report; S&P down for 2nd week May 06 2016
Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of Directors May 05 2016
Endo Reports First Quarter 2016 Financial Results May 05 2016
Endo Announces Change to Senior Management Team May 05 2016
Endo Announces Appearances at Upcoming Conferences May 03 2016
U.S. FTC sues Endo alleging antitrust violations Mar 31 2016
Endo to flag Opana ER painkiller's risks, under NY settlement Mar 03 2016
Endo to flag Opana ER painkiller's risks, under NY settlement Mar 03 2016
US STOCKS-Wall St edges up on China stimulus, higher oil prices Feb 29 2016
US STOCKS-Wall St up slightly on China stimulus, oil price rise Feb 29 2016
Mylan-targeted Perrigo held merger talks with Endo - sources Nov 12 2015
Analysis - Valeant plunge spotlights cracks in specialty pharma's M&A facade Oct 21 2015
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion Jul 28 2015
Hikma to buy Boehringer's U.S. generic drug business for $2.65 bln Jul 28 2015
US HY CLOSE-CNH raises US$600m; Summit to price later Jun 23 2015
US HY CLOSE-Two high-yield issuers tap market for US$2bn Jun 22 2015
Pozen to redomicile as it agrees to buy Tribute Pharmaceuticals Jun 08 2015
Dow, S&P 500 close at record highs May 18 2015
US STOCKS-Dow, S&P close at record highs as rate-hike angst abates May 18 2015
Abandoning Par IPO for $8 billion sale could help TPG with its own May 18 2015
US STOCKS-Dow, S&P hit record highs as rate-hike worries fade May 18 2015
Endo pushes further into generics with $8 billion Par Pharma buy May 18 2015
Endo pushes further into generics with $8 bln Par Pharma buy May 18 2015
US STOCKS-Dow, S&P touch record highs May 18 2015
US STOCKS-Wall St down as homebuilder confidence slips May 18 2015
Endo to buy Par Pharmaceutical for $8.05 bn May 18 2015
US STOCKS-Wall St opens mixed ahead of homebuilder sentiment data May 18 2015
Endo withdraws offer for Salix Mar 16 2015
Analysis - Endo's bid for Salix shows its strategy as Valeant challenger Mar 12 2015
Endo offers about $11 billion for Salix, trumping Valeant Mar 11 2015
Drugmaker Valeant close to buying Salix - source Feb 20 2015
Exclusive - Drugmaker Endo vying for Salix takeover: source Feb 13 2015
U.S. court denies Ranbaxy's bid to block launch of rival generics Nov 20 2014
Auxilium Pharma accepts Endo's buyout offer, drops QLT deal Oct 09 2014
Endo offers to buy Auxilium Pharma for about $2.2 billion Sep 16 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)